Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 30, 2017
AMRI has more than doubled its current bulk API aseptic manufacturing capacity.
read more
AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI’s Singapore site as Director of ...
read more
AMRI has announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic.
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more
AMRI announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
read more
AMRI will now offer its impurity solutions as a stand-alone service.
read more
Wednesday, January 10, 2018
AMRI announced Michael Mulhern has joined the company as chief executive officer, succeeding William S. Marth.
read more
Wednesday, January 09, 2013
AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice ...
read more
AMRI announced today that Susan Collins has been promoted to Director of Business Development for North American Discovery Services, reporting to Christopher Conway, Vice President, Business Development. In this new role, Ms. Collins is responsible ...
read more
Tuesday, February 26, 2013
AMRI announced today that it has promoted Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia. Dr. Yura will report directly to Thomas E. D’Ambra, Ph.D., Chairman, President and CEO.
read more
Tuesday, September 08, 2020
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222.
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
Friday, February 23, 2018
AMRI announced expansion of its industry-leading container closure integrity testing (CCIT) services into the European Union.
read more
Thursday, February 25, 2021
Amyris announced promising preliminary data in a pre-clinical study of its RNA COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
read more
Friday, September 24, 2021
At Pfizer CentreOne we aspire to be the CDMO partner of choice. Over the last several years our team has been working to expand our development services offerings so we can truly be an end-to-end CDMO, from development through to commercial ...
read more